MacroGenics Statistics
Share Statistics
MacroGenics has 62.76M shares outstanding. The number of shares has increased by 1.12% in one year.
| Shares Outstanding | 62.76M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.14% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 57.89M |
| Failed to Deliver (FTD) Shares | 1.87K |
| FTD / Avg. Volume | 0.31% |
Short Selling Information
The latest short interest is 5.46M, so 8.7% of the outstanding shares have been sold short.
| Short Interest | 5.46M |
| Short % of Shares Out | 8.7% |
| Short % of Float | 9.4% |
| Short Ratio (days to cover) | 10.07 |
Valuation Ratios
The PE ratio is -65.77 and the forward PE ratio is -1.7.
| PE Ratio | -65.77 |
| Forward PE | -1.7 |
| PS Ratio | 10.14 |
| Forward PS | 2.1 |
| PB Ratio | 3.9 |
| P/FCF Ratio | -7.45 |
| PEG Ratio | n/a |
Enterprise Valuation
MacroGenics Inc. has an Enterprise Value (EV) of 595.69B.
| EV / Earnings | -65764.18 |
| EV / Sales | 10139.61 |
| EV / EBITDA | 295335.6 |
| EV / EBIT | -3540.64 |
| EV / FCF | -7449.04 |
Financial Position
The company has a current ratio of 4.48, with a Debt / Equity ratio of 0.02.
| Current Ratio | 4.48 |
| Quick Ratio | 4.46 |
| Debt / Equity | 0.02 |
| Total Debt / Capitalization | 2.41 |
| Cash Flow / Debt | -20.72 |
| Interest Coverage | -117.65 |
Financial Efficiency
Return on equity (ROE) is -0.06% and return on capital (ROIC) is -90.17%.
| Return on Equity (ROE) | -0.06% |
| Return on Assets (ROA) | -0.03% |
| Return on Capital (ROIC) | -90.17% |
| Revenue Per Employee | 173.30K |
| Profits Per Employee | -26.72K |
| Employee Count | 339 |
| Asset Turnover | 0.2 |
| Inventory Turnover | 6.73 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -65.44% in the last 52 weeks. The beta is 2.08, so MacroGenics 's price volatility has been higher than the market average.
| Beta | 2.08 |
| 52-Week Price Change | -65.44% |
| 50-Day Moving Average | 3.69 |
| 200-Day Moving Average | 6.98 |
| Relative Strength Index (RSI) | 39.54 |
| Average Volume (20 Days) | 604.50K |
Income Statement
In the last 12 months, MacroGenics had revenue of $58.75M and earned -$9.06M in profits. Earnings per share was $-0.15.
| Revenue | 58.75M |
| Gross Profit | 50.53M |
| Operating Income | -168.24M |
| Net Income | -9.06M |
| EBITDA | 2.02M |
| EBIT | -168.24M |
| Earnings Per Share (EPS) | -0.15 |
Balance Sheet
The company has $100.96M in cash and $33.97M in debt, giving a net cash position of $66.98M.
| Cash & Cash Equivalents | 100.96M |
| Total Debt | 33.97M |
| Net Cash | 66.98M |
| Retained Earnings | -1.10B |
| Total Assets | 264.49M |
| Working Capital | 162.89M |
Cash Flow
In the last 12 months, operating cash flow was -$78.20M and capital expenditures -$1.76M, giving a free cash flow of -$79.97M.
| Operating Cash Flow | -78.20M |
| Capital Expenditures | -1.76M |
| Free Cash Flow | -79.97M |
| FCF Per Share | -1.29 |
Margins
Gross margin is 86%, with operating and profit margins of -286.38% and -15.42%.
| Gross Margin | 86% |
| Operating Margin | -286.38% |
| Pretax Margin | -15.42% |
| Profit Margin | -15.42% |
| EBITDA Margin | 3.43% |
| EBIT Margin | -286.38% |
| FCF Margin | -136.12% |
Dividends & Yields
MGNX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -4.69% |
| FCF Yield | -39.82% |
Analyst Forecast
The average price target for MGNX is $5, which is 56.2% higher than the current price. The consensus rating is "Hold".
| Price Target | $5 |
| Price Target Difference | 56.2% |
| Analyst Consensus | Hold |
| Analyst Count | 10 |
Scores
| Altman Z-Score | -5.15 |
| Piotroski F-Score | 2 |